Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing
Abstract Broadly neutralizing antibodies (bNAbs) targeting the HIV-1 envelope glycoprotein (Env) have the capacity to delay viral rebound when administered to people with HIV-1 (PWH) during anti-retroviral therapy (ART) interruption. To further enhance the performance of bNAbs through their Fc effec...
Main Authors: | Steven W. de Taeye, Angela I. Schriek, Jeffrey C. Umotoy, Marloes Grobben, Judith A. Burger, Rogier W. Sanders, Gestur Vidarsson, Manfred Wuhrer, David Falck, Neeltje A. Kootstra, Marit J. van Gils |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
Nature Portfolio
2024-08-01
|
סדרה: | Communications Biology |
גישה מקוונת: | https://doi.org/10.1038/s42003-024-06659-8 |
פריטים דומים
-
PP 8.8 – 00129 Antibody mediated killing of HIV-1 infected cells with glycoengineered broadly neutralizing antibodies
מאת: S. De Taeye, et al.
יצא לאור: (2022-12-01) -
A functional spleen contributes to afucosylated IgG in humans
מאת: Iwona Wojcik, et al.
יצא לאור: (2021-12-01) -
Acquisition of Fc-afucosylation of PfEMP1-specific IgG is age-dependent and associated with clinical protection against malaria
מאת: Mary Lopez-Perez, et al.
יצא לאור: (2025-01-01) -
Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions
מאת: Angela I. Schriek, et al.
יצא לאור: (2022-11-01) -
Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions
מאת: Angela I. Schriek, et al.
יצא לאור: (2022-05-01)